Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OVID | AMGN | REGN | VRTX | GILD |
| Company | Ovid Therapeutics Inc | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1900 | 325.59 | 1,018.48 | 481.64 | 84.92 |
| High | 1.1900 | 326.95 | 1,023.69 | 487.09 | 85.34 |
| Low | 1.1000 | 322.59 | 1,009.45 | 478.90 | 84.34 |
| Last | 1.1400 | 324.62 | 1,014.25 | 484.82 | 85.05 |
| Change | -0.0100 | -3.73 | -1.42 | +3.11 | +0.10 |
| % Change | -0.87% | -1.14% | -0.14% | +0.65% | +0.12% |
| Volume | 117,500 | 1,613,400 | 497,300 | 743,600 | 3,493,200 |
| 20-Day Average Volume | 123,130 | 2,014,675 | 728,015 | 1,037,665 | 6,830,200 |
| Previous Close | 1.1500 | 328.35 | 1,015.67 | 481.71 | 84.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1295 | 324.56 | 1,052.04 | 466.65 | 84.16 |
| 20-Day Raw Stochastic | 64.71% | 46.13% | 12.40% | 93.90% | 64.21% |
| 20-Day Relative Strength | 49.84% | 49.98% | 36.74% | 56.74% | 64.19% |
| Weighted Alpha | +2.34 | +16.74 | +18.66 | +31.35 | +16.63 |
| Today's Opinion | 48% Sell | 56% Buy | 8% Sell | 48% Buy | 100% Buy |
| Previous Opinion | 48% Sell | 72% Buy | 8% Sell | 48% Buy | 100% Buy |
| Last Month's Opinion | 48% Sell | 88% Buy | 80% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.88% since 10/07/24 | +2.26% since 10/07/24 | +1.83% since 10/07/24 | +8.07% since 10/07/24 | +0.73% since 10/07/24 |
| Low | 1.0300 on 10/11/24 | 314.70 on 10/09/24 | 993.01 on 10/08/24 | 451.11 on 10/08/24 | 84.17 on 10/11/24 |
| High | 1.1900 on 10/14/24 | 329.17 on 10/11/24 | 1,023.69 on 10/14/24 | 487.09 on 10/14/24 | 86.85 on 10/09/24 |
| 1-Month | |||||
| %Chg | -4.20% since 09/13/24 | -2.36% since 09/13/24 | -12.06% since 09/13/24 | -0.11% since 09/13/24 | +2.70% since 09/13/24 |
| Low | 1.0300 on 10/11/24 | 312.16 on 09/25/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 81.83 on 09/26/24 |
| High | 1.2000 on 09/17/24 | 339.17 on 09/23/24 | 1,165.85 on 09/19/24 | 490.15 on 09/16/24 | 86.85 on 10/09/24 |
| 3-Month | |||||
| %Chg | +19.57% since 07/12/24 | -1.88% since 07/12/24 | -7.80% since 07/12/24 | -0.80% since 07/12/24 | +21.57% since 07/12/24 |
| Low | 0.8000 on 08/13/24 | 306.59 on 08/07/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 70.21 on 07/15/24 |
| High | 1.3000 on 08/29/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 86.85 on 10/09/24 |
| 6-Month | |||||
| %Chg | -64.38% since 04/12/24 | +21.45% since 04/12/24 | +12.11% since 04/12/24 | +22.26% since 04/12/24 | +24.94% since 04/12/24 |
| Low | 0.6800 on 06/26/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 3.4500 on 04/30/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 86.85 on 10/09/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 81,587 | 176,138,432 | 111,912,600 | 124,306,712 | 105,835,208 |
| Shares Outstanding, K | 70,945 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 390,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -52,340,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 170,000 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | 8,520,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 0.39 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.12 on 08/13/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/01/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.65 | 26.44 | 0.00 | 18.07 |